Lataa...
Pancreatic adenocarcinoma: Beyond first line, where are we?
Pancreatic cancer is considered one of the most aggressive cancers, with an increasing incidence in recent years. To date, chemotherapy is still the standard of care for advanced metastatic disease, unfortunately providing only a slight advantage in terms of survival. The molecular and cellular char...
Tallennettuna:
| Julkaisussa: | World J Gastroenterol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Baishideng Publishing Group Inc
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8108033/ https://ncbi.nlm.nih.gov/pubmed/34007126 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v27.i17.1847 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|